Difebarbamate

In this article, we are going to explore the impact of Difebarbamate on contemporary society. Difebarbamate has been a key point of interest and debate in various areas, from politics to popular culture. Over the years, Difebarbamate has proven to be a topic of great relevance and influence in people's lives, providing both benefits and challenges for society as a whole. Through detailed analysis, we will examine how Difebarbamate has shaped our beliefs, values ​​and actions, and how its influence extends to different aspects of modern life. Additionally, we will explore the different perspectives and opinions around Difebarbamate, highlighting the complexity and diversity of opinions around this topic. In short, this article offers a deep and exhaustive look at Difebarbamate, addressing its importance and impact on contemporary reality.
Difebarbamate
Clinical data
Routes of
administration
Oral
ATC code
  • None
Identifiers
  • (5-ethyl-2,4,6-trioxo-5-phenyldihydropyrimidine-1,3(2H,4H)-diyl)bis-3-butoxypropane-1,2-diyl dicarbamate
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.036.147 Edit this at Wikidata
Chemical and physical data
FormulaC28H42N4O9
Molar mass578.663 g·mol−1
3D model (JSmol)
  • O=C1N(C(=O)N(C(=O)C1(c2ccccc2)CC)CC(OC(=O)N)COCCCC)CC(OC(=O)N)COCCCC
  • InChI=1S/C28H42N4O9/c1-4-7-14-38-18-21(40-25(29)35)16-31-23(33)28(6-3,20-12-10-9-11-13-20)24(34)32(27(31)37)17-22(41-26(30)36)19-39-15-8-5-2/h9-13,21-22H,4-8,14-19H2,1-3H3,(H2,29,35)(H2,30,36)
  • Key:GJJRIOLBUILIGK-UHFFFAOYSA-N

Difebarbamate (INN) is a tranquilizer of the barbiturate and carbamate families which is used in Europe as a component of a combination drug formulation referred to as tetrabamate (Atrium, Sevrium).

See also

References

  1. ^ Index nominum 2000: international drug directory. Taylor & Francis US. 2000. p. 333. ISBN 978-3-88763-075-1. Retrieved 26 November 2011.
  2. ^ World Health Organization (2004). "The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substance" (PDF).
  3. ^ Vachta J, Valter K, Siegfried B (1990). "Metabolism of difebarbamate in man". European Journal of Drug Metabolism and Pharmacokinetics. 15 (3): 191–8. doi:10.1007/BF03190203. PMID 2253648. S2CID 2916646.